Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Lung Cancer

Free Subscription 10.08.2026 1 Ann Surg 1 Ann Surg Oncol 2 Ann Thorac Surg 1 BMC Cancer 1 Br J Cancer 1 Cancer Chemother Pharmacol 1 Carcinogenesis 2 Clin Lung Cancer 2 Clin Nucl Med 6 Int J Cancer 1 Int J Radiat Oncol Biol Phys 1 J Natl Cancer Inst 1 J Thorac Cardiovasc Surg 9 J Thorac Oncol 4 Lung Cancer 1 Oncogene 2 Oncologist 1 PLoS One 1 Semin Oncol

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Surg

1. SMITH R JR, Erickson K, Washington D, Zollo R, et al
   Exercise Modulates Adiposity-induced Immune Dysfunction in NSCLC and Non-tumor-Bearing Lungs: Implications for Lung Cancer Therapy and Interception.
   Ann Surg. 2026 Aug 6. doi: 10.1097/SLA.0000000000007151.
   PubMed         Abstract available
   
   

   
   Ann Surg Oncol

2. YANG MZ, Chang ZH, Cai JS, Hou X, et al
   De-escalation of Adjuvant EGFR-TKI in Stage IB EGFR-Mutated Non-small-cell Lung Cancer: A Real-World Study.
   Ann Surg Oncol. 2026 Aug 6. doi: 10.1245/s10434-026-20282.
   PubMed         Abstract available
   
   

   
   Ann Thorac Surg

3. BRANDT WS, Eaton DB, Seyoum N, Thomas TS, et al
   Dropout after Neoadjuvant Chemoimmunotherapy for Non-Small Cell Lung Cancer in the Veterans Health Administration.
   Ann Thorac Surg. 2026 Aug 5:S0003-4975(26)00805.
   PubMed         Abstract available
   
   
4. MARTIN LW, Wang X, Kozono D, Urbanic J, et al
   CHIO3: CHemotherapy Combined with Immune Checkpoint Inhibitor for Operable Stage IIIA/B (N2) Non-Small Cell Lung Cancer: Surgical Outcomes.
   Ann Thorac Surg. 2026 Aug 5:S0003-4975(26)00815.
   PubMed         Abstract available
   
   

   
   BMC Cancer

5. LI C, Zhong J, Pan J, Huang S, et al
   Deep learning-based CT radiomics for ALK rearrangement status prediction in lung adenocarcinoma.
   BMC Cancer. 2026;26:922.
   PubMed         Abstract available
   
   

   
   Br J Cancer

6. VAJA S, Dickson JL, Horst C, Mullin ML, et al
   The effect of cigar, cigarillo and pipe smoking on lung cancer risk and screening eligibility.
   Br J Cancer. 2026 Aug 7. doi: 10.1038/s41416-026-03578.
   PubMed         Abstract available
   
   

   
   Cancer Chemother Pharmacol

7. GROOT BEUMER KWM, Durlinger EMJ, Zielhuis SWJ, Ter Heine R, et al
   Dosing challenges for chemotherapy and immunotherapy in congenital achondroplasia: a case report and literature review.
   Cancer Chemother Pharmacol. 2026;96:82.
   PubMed         Abstract available
   
   

   
   Carcinogenesis

8. ZHANG Y, Li M, Dong T, Zhou Y, et al
   Neddylation pathway promotes the ubiquitinated degradation of FBXO21 in lung cancer cells.
   Carcinogenesis. 2026;47:bgag039.
   PubMed         Abstract available
   
   

   
   Clin Lung Cancer

9. YAO Y, Xia X, Zhang L, Hu S, et al
   Incidence of Radiation Pneumonitis Following EGFR-TKI Combined With Thoracic Radiotherapy in Unresectable Stage III or IV Non-Small-Cell Lung Cancer: A Systematic Review and Meta-analysis.
   Clin Lung Cancer. 2026;27:95-107.
   PubMed         Abstract available
   
   
10. BUSHARA O, Ahn S, D'Orleans CC, Farooq MS, et al
    Trends in Surgical Management of Early-stage Small Cell Lung Cancer.
    Clin Lung Cancer. 2026;27:87-94.
    PubMed         Abstract available
    
    

    
    Clin Nucl Med

11. OKSUZOGLU K, Perktas L, Onner H, Yilmaz F, et al
    Dramatic Morphometabolic Response to Bevacizumab-Based Chemotherapy After Immunotherapy Failure in Malignant Pleural Mesothelioma on FDG PET.
    Clin Nucl Med. 2026 Apr 16. doi: 10.1097/RLU.0000000000006495.
    PubMed         Abstract available
    
    
12. XIAO Z, Dong A, Zhang F, Zuo C, et al
    Bone Scintigraphy and FDG PET/CT in a Case of Pulmonary NUT Carcinoma With Only Initial Presentation of Bony Metastasis to the Distal Phalanx of the Little Finger Following Traumatic Injury.
    Clin Nucl Med. 2026 May 15. doi: 10.1097/RLU.0000000000006538.
    PubMed         Abstract available
    
    

    
    Int J Cancer

13. KOTO R, Yamamoto A, Takashima I, Iwao C, et al
    Reply to: Comments on "Survival by Detection Pathway in Patients With Lung Cancer-A Nationwide Descriptive Epidemiological Study in Japan".
    Int J Cancer. 2026 Aug 4. doi: 10.1002/ijc.70678.
    PubMed        
    
    
14. ROSE F, El-Ekiaby N, Wehling L, Weiler SME, et al
    A Serum lncRNA Signature Determines Oncogenic YAP Activity in Cancer Patients.
    Int J Cancer. 2026;159:1829-1843.
    PubMed         Abstract available
    
    
15. BRIERLEY JD, Van Eycken LJ, Giuliani ME, Rous BA, et al
    The 9th Edition of the UICC TNM Classification of Malignant Tumours: Updates and Rationale for Change.
    Int J Cancer. 2026;159:1588-1601.
    PubMed         Abstract available
    
    
16. WANG J, Qi P, Li J, Wang N, et al
    Aumolertinib Versus Osimertinib as First-Line Treatment for EGFR-Mutant Non-Small Cell Lung Cancer: A Retrospective Real-World Multicenter Study.
    Int J Cancer. 2026 Aug 4. doi: 10.1002/ijc.70617.
    PubMed         Abstract available
    
    
17. MATSUZAKA M, Tanaka R
    Comments on 'Survival by Detection Pathway in Patients With Lung Cancer: A Nationwide Descriptive Epidemiological Study in Japan'.
    Int J Cancer. 2026 Aug 5. doi: 10.1002/ijc.70677.
    PubMed        
    
    
18. CAKIR E, Divriklioglu D, Guven DC, Ozel GS, et al
    Diabetes Increases Immunotherapy-Related Toxicity but Not Efficacy in Metastatic Non-Small Cell Lung Cancer: A Multicenter Retrospective Study.
    Int J Cancer. 2026 Aug 6. doi: 10.1002/ijc.70688.
    PubMed         Abstract available
    
    

    
    Int J Radiat Oncol Biol Phys

19. BOSCH F, Damhuis R, Peters M, van Bockel LW, et al
    Real-world data on once or twice daily radiotherapy and the effect of age in patients with limited-stage small cell lung cancer.
    Int J Radiat Oncol Biol Phys. 2026 Aug 5:S0360-3016(26)04113.
    PubMed         Abstract available
    
    

    
    J Natl Cancer Inst

20. KHANDEKAR A, Hoang PH, Luebeck J, Diaz-Gay M, et al
    Examining the role of extrachromosomal DNA in lung cancer.
    J Natl Cancer Inst. 2026 Aug 5:djag273. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Thorac Cardiovasc Surg

21. IMMIDISETTI A, Lin N, Wu J, Adams SV, et al
    Post-Treatment Imaging in Lung Cancer Patients: Adherence to Surveillance Guidelines Is Associated with Improved Survival in a Longitudinal Cohort.
    J Thorac Cardiovasc Surg. 2026 Aug 4:S0022-5223(26)01207.
    PubMed         Abstract available
    
    

    
    J Thorac Oncol

22. TAN AC, Liao BC, Li M, Lee D, et al
    Consensus Statement on ctDNA Minimal Residual Disease Testing in Early Stage NSCLC: A Delphi Study by the Asian Thoracic Oncology Research Group.
    J Thorac Oncol. 2026;21:103696.
    PubMed         Abstract available
    
    
23. SENAN S, Cho BC, Laktionov KK, Zenke Y, et al
    Durvalumab Consolidation in Limited-Stage SCLC: Outcomes by Prior Concurrent Chemoradiotherapy and Prophylactic Cranial Irradiation in the Phase 3 ADRIATIC Trial.
    J Thorac Oncol. 2026;21:103703.
    PubMed         Abstract available
    
    
24. PECCI F, Wang X, Santo V, Gariazzo E, et al
    Tumor mutational burden as a predictor of immune-related adverse events in patients with advanced non-small cell lung cancer receiving immune checkpoint inhibitors: a Brief Report.
    J Thorac Oncol. 2026 Aug 5:104136. doi: 10.1016/j.jtho.2026.104136.
    PubMed         Abstract available
    
    
25. YU H
    Do People Occupationally Exposed to Asbestos-Free Talc Have Elevated Risk for Lung Cancer, Laryngeal Cancer, or Mesothelioma?
    J Thorac Oncol. 2026;21:103929.
    PubMed        
    
    
26. PUJOL JL, Roy UB, Feldman J, Egwuenu C, et al
    Lung Cancer Patient Advocacy Progress and New Challenges Since 2006.
    J Thorac Oncol. 2026;21:103892.
    PubMed         Abstract available
    
    
27. BRUNETTI L, Colella G, Di Fazio GR, La Cava G, et al
    First-Line Integration of Local Ablative Therapy With EGFR Tyrosine Kinase Inhibitors in Advanced EGFR+ NSCLC: A Systematic Review and Meta-Analysis.
    J Thorac Oncol. 2026;21:103735.
    PubMed         Abstract available
    
    
28. SEYYEDSALEHI MS, Powley WA, Boffetta P
    Occupational Exposure to Asbestos-Free Talc and Risk of Respiratory Cancers, Including Larynx, Lung, and Mesothelioma: A Systematic Review and Meta-Analysis.
    J Thorac Oncol. 2026;21:103710.
    PubMed         Abstract available
    
    
29. DOWLATI A, Ferdousi R, Ajay A, Brewster C, et al
    Retinoblastoma-Proficient Small Cell Lung Cancer: A Novel Entity With Therapeutic Vulnerability?
    J Thorac Oncol. 2026;21:103714.
    PubMed         Abstract available
    
    
30. RUBIO-PEREZ J, Daher S, Lin ST, Wilhelm C, et al
    Brief Report: Intestinal Lymphangiectasia With Selpercatinib and Pralsetinib Treatment.
    J Thorac Oncol. 2026;21:103704.
    PubMed         Abstract available
    
    

    
    Lung Cancer

31. MOKKENSTORM K, van Beusekom S, Breukhoven C, Veldman A, et al
    Associated factors regarding systemic anticancer therapy use prior to death among patients with metastatic non-small cell lung cancer: A multicentre retrospective cohort study.
    Lung Cancer. 2026;219:109551.
    PubMed         Abstract available
    
    
32. WANG K, Yi C, Ning X, Xiong D, et al
    BRAF fusions define therapeutic vulnerability and tyrosine kinase inhibitor resistance in non-small cell lung cancer.
    Lung Cancer. 2026;219:109556.
    PubMed         Abstract available
    
    
33. DHILIPKANNAH P, Jiang F
    Coordinated microbial-inflammatory associations in never-smoking lung cancer.
    Lung Cancer. 2026;219:109561.
    PubMed         Abstract available
    
    
34. ISHIOKA K, Nishio M, Ninomiya H, Yanagitani N, et al
    Clinical characteristics and management of Li-Fraumeni syndrome-associated lung cancer.
    Lung Cancer. 2026;219:109559.
    PubMed         Abstract available
    
    

    
    Oncogene

35. JIA E, Zhang H, Zhang L, Li L, et al
    SRD5A3-mediated aberrant N-glycosylation of SCARA5 promotes ferroptosis in lung adenocarcinoma.
    Oncogene. 2026;45:3299-3313.
    PubMed         Abstract available
    
    

    
    Oncologist

36. JONES S, Falchook G, Graff S, Arrowsmith E, et al
    A phase II study to evaluate the efficacy of commercially available molecularly matched targeted therapies in the second-line setting.
    Oncologist. 2026;31:oyag279.
    PubMed         Abstract available
    
    
37. ALBERS-LEISCHNER C, Ritgen M, Paulsen FO, Schmidt B, et al
    Molecular tumor board-guided osimertinib therapy in EGFR L858R/Q701L-mutant lung adenocarcinoma supported by functional validation.
    Oncologist. 2026;31:oyag242.
    PubMed         Abstract available
    
    

    
    PLoS One

38. MELLOR P, Kendall S, Anderson DH
    2-methoxyestradiol is effective in 2D and 3D models of NCI-H2170 lung squamous cell carcinoma cells.
    PLoS One. 2026;21:e0355486.
    PubMed         Abstract available
    
    

    
    Semin Oncol

39. YILDIRIM I, Avci CB
    Exosomes as emerging biomarkers in breast, lung, and colorectal cancer diagnosis: A comprehensive review.
    Semin Oncol. 2026;53:152497.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum